The medical laser systems market in South & Central America is expected to grow from US$ 136.23 million in 2021 to US$ 318.31 million by 2028; it is estimated to grow at a CAGR of 12.9% from 2021 to 2028.
Various economies are witnessing considerable modernization of healthcare facilities and improvements in healthcare services. With this, the life expectancy of people in these countries has increased, leading to an expansion in their geriatric population base. Ophthalmic diseases constitute a significant share of health problems among older people. Age-related macular degeneration resulting in loss of central vision, glaucoma, retinal detachment, cataracts, and diabetic retinopathy are among the most common ophthalmic diseases among the geriatric population. Diabetic retinopathy is also common among older people during the early stages of diabetes or at the time of the diagnosis. A mydriatic examination is recommended when a patient is diagnosed with diabetes and once a year after that. Furthermore, glaucoma cases are on the rise. So, there is a potential for the adoption of new technology, such as femtosecond lasers, in cataract surgery, which involves a large upfront investment but promises to improve patient outcomes. All these factors are driving the medical laser systems market.
Alcon Inc; Artivion, Inc.; Bausch Health Companies Inc.; BIOLASE, Inc.; Boston Scientific Corporation; Candela Medical; Iridex Corporation; Koninklijke Philips N.V.; and Lumenis Be Ltd. are among the leading companies operating in the South & Central America medical laser systems market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Various economies are witnessing considerable modernization of healthcare facilities and improvements in healthcare services. With this, the life expectancy of people in these countries has increased, leading to an expansion in their geriatric population base. Ophthalmic diseases constitute a significant share of health problems among older people. Age-related macular degeneration resulting in loss of central vision, glaucoma, retinal detachment, cataracts, and diabetic retinopathy are among the most common ophthalmic diseases among the geriatric population. Diabetic retinopathy is also common among older people during the early stages of diabetes or at the time of the diagnosis. A mydriatic examination is recommended when a patient is diagnosed with diabetes and once a year after that. Furthermore, glaucoma cases are on the rise. So, there is a potential for the adoption of new technology, such as femtosecond lasers, in cataract surgery, which involves a large upfront investment but promises to improve patient outcomes. All these factors are driving the medical laser systems market.
South & Central America Medical Laser Systems Market Segmentation
The South & Central America medical laser systems market is segmented based on product type, application, end user, and country. Based on product type, the market has been segmented into diode lasers, solid state lasers, gas lasers, fiber lasers and dye lasers. In 2020, the solid state lasers segment held the largest share of the market. The solid state lasers segment is subsegmented into holmium yttrium aluminum garnet (Ho:Yag) lasers, erbium yttrium aluminum garnet (Er:Yag) lasers, neodynium yttrium aluminum garnet (Nd:Yag) lasers, thulium:yttrium-aluminum-garnet laser (Tm:YAG), potassium titanyl phosphate (KTP), alexandrite lasers, and ruby lasers. In 2020, the erbium yttrium aluminum garnet (Er:Yag) lasers segment held the largest share. Based on gas lasers, the market is subsegmented into CO2 laser, argon laser, krypton laser, metal vapor laser, helium neon laser, and excimer laser. In 2020, the CO2 laser segment held the largest share. Based on fiber lasers, the market is subsegmented into thulium fiber lasers, erbium fiber lasers, and ytterbium fiber lasers. In 2020, the thulium fiber lasers segment held the largest share. Based on application, the market has been segmented into dermatology, ophthalmology, gynecology, dentistry, cardiology, urology, and others. In 2020, the dermatology segment held the largest market share. Based on end user, the market is segmented into hospitals, specialty clinics, ambulatory surgery centers, and others. In 2020, the specialty clinics segment held the largest market share. Similarly, based on country, the market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil contributed a substantial share in 2020.Alcon Inc; Artivion, Inc.; Bausch Health Companies Inc.; BIOLASE, Inc.; Boston Scientific Corporation; Candela Medical; Iridex Corporation; Koninklijke Philips N.V.; and Lumenis Be Ltd. are among the leading companies operating in the South & Central America medical laser systems market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Table of Contents
1. Introduction
3. Research Methodology
4. SCAM Medical Lasers Systems Market - Market Landscape
5. SCAM Medical Laser Systems Market - Key Market Dynamics
6. Medical Laser Systems Market- SCAM Analysis
7. SCAM Medical Lasers Market- By Product Type
8. SCAM Medical Laser Systems Market- By Application
9. SCAM Medical Laser Systems Market - By End User
10. SCAM Medical Laser Systems Market- Country Analysis
11. SCAM Medical Laser System Market-Industry Landscape
12. Company Profiles
13. Appendix
List of Figures
List of Tables
Companies Mentioned
- Alcon Inc
- Artivion, Inc.
- Bausch Health Companies Inc.
- BIOLASE, Inc.
- Boston Scientific Corporation
- Candela Medical
- Iridex Corporation
- Koninklijke Philips N.V.
- Lumenis Be Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 179 |
Published | July 2022 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( USD | $ 136.23 Million |
Forecasted Market Value ( USD | $ 318.31 Million |
Compound Annual Growth Rate | 12.9% |
No. of Companies Mentioned | 9 |